XML 30 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity
3 Months Ended
Dec. 31, 2017
Equity [Abstract]  
Equity
Equity

Equity Plans
We provide long-term incentives to eligible officers, directors, and employees in the form of equity-based awards. We maintain three equity incentive compensation plans, collectively described below as our “Equity Plans”:

the 2000 Stock Option Plan,
the 2010 Equity Incentive Plan (“2010 Plan”), and
the 2012 Equity Incentive Plan (“2012 Plan”).

We issue new shares of common stock to satisfy awards issued under our Equity Plans.

Stock Options
Most of our stock options vest and become exercisable over a four to five year period and have a contractual life of 10 years. Certain stock options awarded are intended to qualify as incentive stock options pursuant to Section 422A of the Internal Revenue Code.

The following table summarizes stock option activity under the Equity Plans for the three months ended December 31, 2017:


Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average
Remaining Contractual Life
(in years)
 
Aggregate Intrinsic Value (*) (in thousands)
Outstanding as of September 30, 2017
326,798

 
$19.54
 
 
 
 
Granted

 

 
 
 
 
Exercised
(3,479
)
 
$4.50
 
 
 
$
13

Forfeited
(780
)
 
$4.22
 
 
 
 
Expired
(12,941
)
 
$27.59
 
 
 
 
Outstanding as of December 31, 2017
309,598

 
$19.41
 
1.70
 
$
143

Exercisable as of December 31, 2017
267,946

 
$21.71
 
0.76
 
$
67

Vested and expected to vest as of December 31, 2017
309,598

 
$19.41
 
1.70
 
$
143


(*) Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option's exercise price and the underlying stock price. For the three months ended December 31, 2016, the intrinsic value of options exercised was $0.1 million.

As of December 31, 2017, there was approximately $0.1 million of unrecognized stock-based compensation expense related to non-vested stock options granted under the Equity Plans which is expected to be recognized over an estimated weighted average life of 2.6 years.

Valuation Assumptions
There were no stock option grants for the three months ended December 31, 2017 and 2016.

Time-Based Restricted Stock
Time-based restricted stock units (“RSUs”) and restricted stock awards (“RSAs”) granted to employees under the 2010 Plan and 2012 Plan typically vest over 3 to 4 years and are subject to forfeiture if employment terminates prior to the lapse of the restrictions. RSUs are not considered issued or outstanding common stock until they vest. RSAs are considered issued and outstanding on the grant date and are subject to forfeiture if specified vesting conditions are not satisfied.

The following table summarizes the activity related to RSUs and RSAs subject to time-based vesting requirements for the three months ended December 31, 2017:

Restricted Stock Activity
 
Restricted Stock Units
 
Restricted Stock Awards
 
Number of Shares
 
Weighted Average Grant Date Fair Value
 
Number of Shares
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2017
 
778,084

 
$5.91
 
8,154

 
$8.20
Granted
 
224,600

 
$6.73
 

 
$0.00
Vested
 
(40,095
)
 
$7.09
 

 
$0.00
Forfeited
 
(7,580
)
 
$4.02
 

 
$0.00
Non-vested as of December 31, 2017
 
955,009

 
$6.07
 
8,154

 
$8.20


As of December 31, 2017, there was approximately $4.4 million of remaining unamortized stock-based compensation expense associated with RSUs, which will be expensed over a weighted average remaining service period of approximately 2.5 years. The 1.0 million outstanding non-vested and expected to vest RSUs have an aggregate intrinsic value of approximately $6.2 million and a weighted average remaining contractual term of 1.5 years. For the three months ended December 31, 2017 and 2016, the intrinsic value of RSUs vested was approximately $0.3 million and $32,000, respectively. For the three months ended December 31, 2016, the weighted average grant date fair value of RSUs granted was $7.29.

As of December 31, 2017, there was approximately $0.1 million of remaining unamortized stock-based compensation expense associated with RSAs, which will be expensed over a weighted average remaining service period of approximately 2.8 years.

On December 28, 2017, the Company granted our CEO, Jeffrey Rittichier, our Senior Vice President of Engineering, Albert Lu, and our Vice President of Sales, David Wojciechowski, 40,000, 14,000 and 10,000 RSUs with a grant date fair value of $0.3 million, $0.1 million and $0.1 million, respectively, that will vest in 4 equal annual installments beginning on December 28, 2018.

Performance Stock
Performance based restricted stock units (“PSUs”) and performance based shares of restricted stock (“PRSAs”) granted to employees under the 2012 Plan typically vest over 1 to 3 years and are subject to forfeiture in whole, if employment terminates, or in whole or in part, if specified vesting conditions are not satisfied, in each case prior to vesting. PSUs are not considered issued or outstanding common stock until they vest. PRSAs are considered issued and outstanding on the grant date (at 200% of the target number of shares) and are subject to forfeiture if specified vesting conditions are not satisfied. PSUs and PRSAs that are granted to our executive officers and key employees are provided as long-term incentive compensation that is based on relative total shareholder return, which measures our performance against that of our competitors.

 

The following table summarizes the activity related to PSUs and PRSAs for the three months ended December 31, 2017:

Performance Stock Activity
 
Performance Stock Units
 
Performance Stock Awards
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2017
 
328,708

 
$8.36
 
33,333

 
$12.25
Granted
 
240,164

 
$7.62
 

 
$0.00
Vested
 
(166,058
)
 
$6.86
 

 
$0.00
Non-vested as of December 31, 2017
 
402,814

 
$8.54
 
33,333

 
$12.25


As of December 31, 2017, there was approximately $2.5 million of remaining unamortized stock-based compensation expense associated with PSUs, which will be expensed over a weighted average remaining service period of approximately 2.1 years. The 0.4 million outstanding non-vested and expected to vest PSUs have an aggregate intrinsic value of approximately $2.6 million and a weighted average remaining contractual term of 2.1 years. For the three months ended December 31, 2017, the intrinsic value of PSUs vested was approximately $1.4 million.

As of December 31, 2017, there was approximately $0.4 million of remaining unamortized stock-based compensation expense associated with PRSAs, which will be expensed over a weighted average remaining service period of approximately 1.8 years.

On December 28, 2017, the Company granted Messrs. Rittichier, Lu and Wojciechowski, 40,000, 14,000 and 10,000 PSUs with a grant date fair value of $0.3 million, $0.1 million and $0.1 million, respectively. The PSUs issued will vest based on a combination of the relative total shareholder return of EMCORE’s stock compared to the Russell Microcap Index and the executive's continued employment. The total number of shares to be issued to each individual ranges from zero (0) to 200% of the target PSUs granted. Between zero (0) and 200% of the target PSUs will vest, if at all, on December 28, 2020.

On December 28, 2017, in addition to the PSUs granted to Messrs. Rittichier, Lu and Wojciechowski, the Company granted 108,500 target PSUs with a grant date fair value of $0.9 million to certain key non-executive employees. The PSUs issued will vest based on a combination of the relative total shareholder return of EMCORE’s stock compared to the Russell Microcap Index and the employee's continued employment. The total number of shares to be issued to each individual may range from zero (0) to 200% of the target PSUs granted. Between zero (0) and 200% of the target PSUs granted will vest, if at all, on December 28, 2020.

Stock-based compensation.

The effect of recording stock-based compensation expense was as follows:

Stock-based Compensation Expense - by award type
For the three months ended December 31,
(in thousands)
2017
 
2016
Employee stock options
$
10

 
$
11

Restricted stock units and awards
451

 
354

Performance stock units and awards
289

 
268

Employee stock purchase plan
86

 
52

Outside director fees in common stock
79

 
78

Total stock-based compensation expense
$
915

 
$
763




Stock-based Compensation Expense - by expense type
For the three months ended December 31,
(in thousands)
2017
 
2016
Cost of revenue
$
139

 
$
93

Selling, general, and administrative
638

 
570

Research and development
138

 
100

Total stock-based compensation expense
$
915

 
$
763



The stock-based compensation expense above relates to continuing operations. Included within discontinued operations is $0 and $9,000 of stock based compensation expense for the three months ended December 31, 2017 and 2016, respectively.

401(k) Plan
We have a savings plan that qualifies as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Under this savings plan, participating employees may defer a portion of their pretax earnings, up to the Internal Revenue Service annual contribution limit. Since June 2015, all employer contributions are made in cash. Our matching contribution in cash for the three months ended December 31, 2017 and 2016 was approximately $0.1 million.

Income (Loss) Per Share
The following table sets forth the computation of basic and diluted net (loss) income per share:

Basic and Diluted Net (Loss) Income Per Share
 
For the three months ended December 31,
(in thousands, except per share)
 
2017
 
2016
Numerator:
 
 
 
 
   (Loss) income from continuing operations
 
$
(82
)
 
$
1,766

   Loss from discontinued operations
 

 
(9
)
Undistributed earnings allocated to common shareholders for basic and diluted net income per share
 
(82
)
 
1,757

Denominator:
 
 
 
 
Denominator for basic net income per share - weighted average shares outstanding
 
27,032

 
26,279

Dilutive options outstanding, unvested stock units, unvested stock awards and ESPP
 

 
760

Denominator for diluted net income per share - adjusted weighted average shares outstanding
 
27,032

 
27,039

 
 
 
 
 
Net (loss) income per basic share:
 
 
 
 
   Continuing operations
 
$
(0.00
)
 
$
0.07

   Discontinued operations
 
0.00

 
(0.00
)
Net (loss) income per basic share
 
$
(0.00
)
 
$
0.07

 
 
 
 
 
Net (loss) income per diluted share:
 
 
 
 
   Continuing operations
 
$
(0.00
)
 
$
0.07

   Discontinued operations
 
0.00

 
0.00

Net (loss) income per diluted share
 
$
(0.00
)
 
$
0.07

Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation
 
911

 
529

 
 
 
 
 
Average market price of common stock
 
$
7.50

 
$
6.88



For diluted (loss) income per share, the denominator includes all outstanding common shares and all potential dilutive common shares to be issued. The anti-dilutive stock options and unvested stock were excluded from the computation of diluted net loss per share for the three months ended December 31, 2017 due to the Company incurring a net loss for the period. For the three months ended December 31, 2016, we excluded 0.5 million of weighted average outstanding stock options, RSUs and PSUs from the calculation of diluted net income per share because their effect would have been anti-dilutive.
Employee Stock Purchase Plan
We maintain an Employee Stock Purchase Plan (“ESPP”) that provides employees an opportunity to purchase common stock through payroll deductions. The ESPP is a 6-month duration plan with new participation periods beginning on February 25 and August 26 of each year. The purchase price is set at 85% of the average high and low market price of our common stock on either the first or last trading day of the participation period, whichever is lower, and annual contributions are limited to the lower of 10% of an employee's compensation or $25,000.

Future Issuances 
As of December 31, 2017, we had common stock reserved for the following future issuances:
Future Issuances
Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options
309,598

Unvested restricted stock units
955,009

Unvested performance stock units
805,628

Purchases under the employee stock purchase plan
911,071

Issuance of stock-based awards under the Equity Plans
1,882,779

Purchases under the officer and director share purchase plan
88,741

Total reserved
4,952,826